Fmr LLC Forte Biosciences, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Forte Biosciences, Inc. stock. As of the latest transaction made, Fmr LLC holds 128 shares of FBRX stock, worth $907. This represents 0.0% of its overall portfolio holdings.

Number of Shares

128

Holding current value

$907

% of portfolio

0.0%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.46 - $0.78 $58 - $99	128 New	128 $0
Q2 2022 Aug 12, 2022	BUY	$1.07 - $1.55 $291 - $421	272 Added 86.08%	588 $1,000
Q1 2022 May 13, 2022	BUY	$1.21 - $2.24 $382 - $707	316 New	316 $0

Others Institutions Holding FBRX

# of Institutions

Shares Held

19M

Call Options Held

3.1K

Put Options Held

Tybourne Capital Management (Hk) LTD Hong Kong, K3

3.62M
Shares

$25.7 Million
0.49% of portfolio
Perceptive Advisors LLC New York, NY

3.27M
Shares

$23.2 Million
0.05% of portfolio
Bvf Inc San Francisco, CA

2.98M
Shares

$21.1 Million
0.05% of portfolio
Cable Car Capital LLC San Francisco, CA

2.03M
Shares

$14.4 Million
1.15% of portfolio
Fred Alger Management, LLC New York, NY

1.84M
Shares

$13 Million
0.0% of portfolio

View Full List

About Forte Biosciences, Inc.

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $144M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

More about FBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account